Reported Oct 31, 2018 · Terminated

Bumetanide Tablets, USP, 1 mg, 100-count bottle, Rx only, Manufactured by: Upser-Smith Laboratories, LLC, Maple Grove,…

Upsher Smith Laboratories, Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Upsher Smith Laboratories, Inc. · 6701 Evenstad Dr N · Maple Grove, MN · 55369-6026

Is this the product you have?

  • Bumetanide Tablets, USP, 1 mg, 100-count bottle, Rx only
  • Manufactured byUpser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0541-11
Lot codes and dates
    • Lot#: 375716
    • Exp 4/30/2020
    • 372957
    • 372958
    • 372959
    • Exp 3/31/2020
    • 374541
    • 375717
    • 376688
    • Exp 5/31/2020
Amount recalled
44,764 bottles

This recall covers 2 products

The agency filed one notice per product. You are reading one of them; the other one is below.

Where it was sold

  • Nationwide
  • PR

Why it was recalled

Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Upsher Smith Laboratories, Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Sep 30, 2020 · Data as of Sep 19, 8:08 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.